The objectives of the LEGATO Project in the words of Principal Investigator and Co-Leader Prof. Dr Matthias Preusser
LEGATO is part of a series of clinical trials funded by the Horizon Europe programme as part of...
LEGATO is part of a series of clinical trials funded by the Horizon Europe programme as part of...
Over the last couple of months, we introduced the people and organisations behind the LEGATO Project on our...
The European Organisation for Research and Treatment of Cancer (EORTC) and the Syreon Research Institute are delighted to...
© The LEGATO Consortium 2023-2028. This project has received funding from the European Union’s HORIZON-MISS-CANCER-2022-01 under grant agreement Nº (101103655). Views and opinions expressed are however those of the authors only and do not necessarily reflect those of the European Union. Neither the European Union nor the granting authority can be held responsible for them.
Copyright © 2024 All rights reserved.
